Herzlia, Israel

Mira Peled Kamar

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 10.8

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Mira Peled Kamar: Pioneering Cancer Treatment Innovations

Introduction

Mira Peled Kamar is a distinguished inventor based in Herzlia, Israel, known for her groundbreaking work in the field of cancer treatment. With two patents to her name, she has made significant contributions that enhance the prospects of targeted therapies.

Latest Patents

Mira's latest patents focus on innovative antibodies with the capacity to bind HLA-A2/Tyrosinase (TyrD) in a restricted manner. These antibodies are designed to bind specifically to the HLA-A2/TyrD369-377 sequence, demonstrating potential applications in cancer treatment. Additionally, she has developed affinity binding entities featuring a TCR-like antibody binding domain, displaying high affinity and specificity for HLA-A2/WT1+, HLA-A2/MAGE-A4, HLA-A2/MAGE-A9, HLA-A2/PAP, and HLA-A2/TyrD+ cells. These entities are aimed at advancing diagnostics and therapeutic options for cancer patients.

Career Highlights

Throughout her career, Mira has been recognized for her innovative spirit and research acumen. Her work has significantly impacted the landscape of immunotherapy, contributing to the evolution of treatment methodologies that can directly target cancer cells. The effectiveness of her patented inventions holds promise for improving cancer treatment outcomes.

Collaborations

Mira has collaborated with notable professionals in her field, including Galit Denkberg and Yoram Reiter. Together, they have worked towards pushing the boundaries of current scientific understanding in cancer therapies, emphasizing the importance of teamwork in achieving significant breakthroughs.

Conclusion

Mira Peled Kamar stands out as a formidable inventor whose contributions to cancer treatment innovations reflect her dedication to improving patient care. With a keen focus on antibody development and their applications, she continues to influence the medical field and inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…